Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares were up 19.3% on Friday . The company traded as high as GBX 1.70 and last traded at GBX 1.67. Approximately 619,121 shares changed hands during mid-day trading, an increase of 39% from the average daily volume of 444,710 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Stock Up 21.4%
The company has a debt-to-equity ratio of -54.35, a quick ratio of 4.66 and a current ratio of 0.48. The firm has a market capitalization of £6.74 million, a price-to-earnings ratio of -5.31 and a beta of 0.38. The firm has a fifty day moving average price of GBX 1.50 and a 200 day moving average price of GBX 1.54.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- J.P. Morgan is betting on this coin
- 1,500 Banks Just Handed the Fed Your Bank Account
- Your name isn’t on our protected list yet
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
